ArticleOncoTargets and therapy2018

Prolyl hydroxylase domain 3 influences the radiotherapy efficacy of pancreatic cancer cells by targeting hypoxia-inducible factor-1α.

Li-Rui Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.